Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomised double-blind trial

This publication has 24 references indexed in Scilit:

• Levosimendan
  Drugs, 2001
• Acute Hemodynamic and Clinical Effects of Levosimendan in Patients With Severe Heart Failure
  Circulation, 2000
• Effects of levosimendan on cardiac arrhythmia: electrophysiologic and ambulatory electrocardiographic findings in phase II and phase III clinical studies in cardiac failure
  The American Journal of Cardiology, 1999
• Influence of levosimendan, pimobendan, and milrinone on the regional distribution of cardiac output in anaesthetized dogs
  British Journal of Pharmacology, 1996
• Effect of pimobendan on exercise capacity in patients with heart failure: main results from the Pimobendan in Congestive Heart Failure (PICO) trial.
  Heart, 1996
• Cardiac troponin C as a target protein for a novel calcium sensitizing drug, levosimendan
  Journal of Molecular and Cellular Cardiology, 1995
• Troponin C–Mediated Calcium Sensitization Induced by Levosimendan Does Not Impair Relaxation
  Journal of Cardiovascular Pharmacology, 1995
• Effects of Calcium Sensitizers on Intracellular Calcium Handling and Myocardial Energetics
  Journal of Cardiovascular Pharmacology, 1995
• Effect of Oral Milrinone on Mortality in Severe Chronic Heart Failure
  New England Journal of Medicine, 1991
• Sustained improvement of cardiac function in patients with congestive heart failure after short-term infusion of dobutamine.
  Circulation, 1984